Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Impact of caryolanemagnolol on gait and functional mobility on individuals with Huntington's disease

Ran Du

Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 471000, China;

For correspondence:- Email: duran19665@gmail.com Tel:+8637166913114

Received: 4 March 2015 Accepted: 30 July 2015 Published: 29 September 2015

Citation: Du R. Impact of caryolanemagnolol on gait and functional mobility on individuals with Huntington's disease. Trop J Pharm Res 2015; 14(9):1713-1717 doi: 10.4314/tjpr.v14i9.24

© 2015 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To highlight the impact of caryolanemagnolol on gait measures in forward walking, balance and mobility measures, as well as in hand and forearm function measures.

Methods: Twenty patients with Huntington’s disease (HD) on stable doses of caryolanemagnolol were evaluated after medication and again following resumption of medication. The improvement in spatiotemporal gait parameters was measured by GAITRite, balance and/or mobility using Tinetti mobility test (TMT), five times sit-to-stand test (5TSST), and six-condition Romberg tests, as well as the function of the hand and forearm by finger tapping and Luria tests on Huntington's disease rating scale (UHDRS) motor scale.

Results: The results demonstrated significant improvement in the unified UHDRS motor scores, Tinetti mobility test (TMT) total and balance subscale scores, and the five times sit-to-stand test when on-caryolanemagnolol compared to off-caryolanemagnolol. Spatiotemporal gait measures, the six condition Romberg test, and UHDRS hand and forearm function items remained unaffected on caryolanemagnolol treatment. Improved TMT and 5TSST performance when on drug indicates that caryolanemagnolol use may improve balance and functional mobility in individuals with HD.

Conclusion: Caryolanemagnolol improves chorea and functional mobility by improving dynamic balance in individuals without any negative impact on motor function in walking and transfers.

Keywords: Huntington's disease, Caryolanemagnolol, Gait measures, Choreic movements, Mobility tests